Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease / Rogliani, P; Calzetta, L; Matera, Mg; di Daniele, N; Girolami, A; Cazzola, M; Ora, J. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 20:6(2019), pp. 737-750. [10.1080/14656566.2019.1570133]

Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease

Calzetta L;
2019-01-01

2019
Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease / Rogliani, P; Calzetta, L; Matera, Mg; di Daniele, N; Girolami, A; Cazzola, M; Ora, J. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 20:6(2019), pp. 737-750. [10.1080/14656566.2019.1570133]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2878044
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
social impact